The wide variation in symptoms of neurological disorders among patients necessitates uncovering individual pathologies for accurate clinical diagnosis and treatment. Current methods attempt to generalize specific biomarkers to explain individual pathology, but they often lack analysis of the underlying pathogenic mechanisms, leading to biased biomarkers and unreliable diagnoses. To address this issue, we propose a motif-induced subgraph generative learning model (MSGL), which provides multi-tiered biomarkers and facilitates explainable diagnoses of neurological disorders. MSGL uncovers underlying pathogenic mechanisms by exploring representative connectivity patterns within brain networks, offering motif-level biomarkers to tackle the challenge of clinical heterogeneity. Furthermore, it utilizes motif-induced information to generate enhanced brain network subgraphs as personalized biomarkers for identifying individual pathology. Experimental results demonstrate that MSGL outperforms baseline models. The identified biomarkers align with recent neuroscientific findings, enhancing their clinical applicability.
Competing Interest StatementThe authors have declared no competing interest.
Funding StatementThis study did not receive any funding
Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://fcon_1000.projects.nitrc.org/indi/abide/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Comments (0)